Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2093021 | 0.86 | HDAC6 (0.36) | HDAC6 | |
| SCHEMBL28726906 | 0.84 | CA12 (0.40) | HDAC6 | |
| SCHEMBL1589356 | 0.84 | HTT (0.35) | HTT | |
| SCHEMBL28868686 | 0.82 | CA12 (0.42) | HDAC6 | |
| SCHEMBL19857514 | 0.82 | HTT (0.31) | HTT | |
| SCHEMBL28726935 | 0.81 | CA1 (0.36) | IDO1 | |
| SCHEMBL18774756 | 0.79 | — | — | |
| Ethylene SCHEMBL11404296 | 0.79 | ALDH1A1 (0.32) | HTT | |
| SCHEMBL19379541 | 0.79 | CES2 (0.39) | HTT | |
| SCHEMBL28903671 | 0.79 | CES2 (0.34) | HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114395117-B | Double-end perfluoropolyether and preparation method thereof | 西安近代化学研究所 | 2023-10-20 | — | — | CN | claimed |
| CN-114395119-B | Binary copolymerization perfluoropolyether and preparation method thereof | 西安近代化学研究所 | 2023-06-09 | — | — | CN | claimed |
| CN-114395117-A | Double-end perfluoropolyether and preparation method thereof | 西安近代化学研究所 | 2022-04-26 | — | — | CN | claimed |
| CN-114395119-A | Binary copolymerization perfluoropolyether and preparation method thereof | 西安近代化学研究所 | 2022-04-26 | — | — | CN | claimed |
| CN-114395117-B | Double-end perfluoropolyether and preparation method thereof | 西安近代化学研究所 | 2023-10-20 | — | — | CN | disclosed |
| CN-114395119-B | Binary copolymerization perfluoropolyether and preparation method thereof | 西安近代化学研究所 | 2023-06-09 | — | — | CN | disclosed |
| CN-114395119-A | Binary copolymerization perfluoropolyether and preparation method thereof | 西安近代化学研究所 | 2022-04-26 | — | — | CN | disclosed |
| CN-114395117-A | Double-end perfluoropolyether and preparation method thereof | 西安近代化学研究所 | 2022-04-26 | — | — | CN | disclosed |
| US-8426437-B2 | Pyrroloquinoline derivatives and their use as protein kinases inhibitors | PIERRE FABRE MEDICAMENT (FR) | 2013-04-23 | — | — | US | disclosed |
| US-20110201657-A1 | AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2011-08-18 | — | — | US | disclosed |
| US-20090275619-A1 | Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2009-11-05 | — | — | US | disclosed |
| US-20090042876-A1 | Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors | PIERRE FABRE MEDICAMENT (FR) | 2009-02-12 | — | — | US | disclosed |
| US-7462451-B2 | Compositions for modifying nucleic acids | THIRD WAVE TECHNOLOGIES, INC. (US) | 2008-12-09 | — | — | US | disclosed |
| US-20050277138-A1 | Reactive functional groups | THIRD WAVE TECHNOLOGIES, INC. (US) | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275619-A1 | Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors | PARP1, PARP3, PARP2 | IDO1 528/4885HDAC6 470/4885HTT 834/4885 |
| US-20110201657-A1 | AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS | PARP1, PARP3, PARP2 | IDO1 528/4885HDAC6 470/4885HTT 834/4885 |
| US-20090042876-A1 | Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors | MAP3K1, MAP3K2, MAP3K7 | IDO1 1964/4885HDAC6 704/4885HTT 2443/4885 |
| US-20050277138-A1 | Reactive functional groups | RNGTT, POLRMT, NSUN2 | IDO1 4202/4885HDAC6 1826/4885HTT 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.